Effect of centralization on long‐term survival after resection of pancreatic ductal adenocarcinoma.
Published: 18th May 2017
Authors: R. Ahola, A. Siiki, K. Vasama, M. Vornanen, J. Sand, J. Laukkarinen et al.
Centralization of pancreatic surgery has resulted in improved short‐term outcomes in a number of healthcare systems. The aim of this study was to see whether hospital volume influenced long‐term prognosis, use of adjuvant therapy or histopathological evaluation of patients undergoing surgical resection for pancreatic ductal adenocarcinoma (
Patients undergoing surgical resection of
Some 467 patients who had undergone resectional surgery for
Both short‐ and long‐term survival was significantly better for patients operated on in
You may also be interested in
Systematic review of transarterial embolization for hepatocellular adenomas. BJS 2017; 104: 823-835.
Authors: B. V. van Rosmalen, R. J. S. Coelen, M. Bieze, O. M. van Delden, J. Verheij, C. H. C. Dejong et al.
Notes: Safe alternative to surgery
Meta‐analysis of adjuvant therapy following curative surgery for periampullary adenocarcinoma. BJS 2017; 104: 814-822.
Authors: A. Acharya, S. R. Markar, M. H. Sodergren, G. Malietzis, A. Darzi, T. Athanasiou et al.
Notes: No benefit
Authors: T. Ebata, T. Mizuno, Y. Yokoyama, T. Igami, G. Sugawara, M. Nagino et al.
Notes: irresectability revisited
Survival benefit of liver resection for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma. BJS 2017; 104: 1045-1052.
Authors: H. Kim, S. W. Ahn, S. K. Hong, K. C. Yoon, H.‐S. Kim, Y. R. Choi et al.
Notes: Selected patients benefit
Accuracy of circulating histones in predicting persistent organ failure and mortality in patients with acute pancreatitis.
Authors: T. Liu, W. Huang, P. Szatmary, S. T. Abrams, Y. Alhamdi, Z. Lin et al.
Notes: Potential as early prediction biomarker
Dual hypothermic oxygenated machine perfusion in liver transplants donated after circulatory death. BJS 2017; 104: 907-917.
Authors: R. van Rijn, N. Karimian, A. P. M. Matton, L. C. Burlage, A. C. Westerkamp, A. P. van den Berg et al.
Notes: Increases donor pool
Prospective trial to evaluate the prognostic value of different nutritional assessment scores in pancreatic surgery (NURIMAS Pancreas). BJS 2017; 104: 1053-1062.
Authors: P. Probst, S. Haller, T. Bruckner, A. Ulrich, O. Strobel, T. Hackert et al.
Notes: No score of use
Authors: F. J. Hüttner, P. Probst, P. Knebel, O. Strobel, T. Hackert, A. Ulrich et al.
Notes: No benefit
Prognostic impact of margin status in liver resections for colorectal metastases after bevacizumab. BJS 2017; 104: 926-935.
Authors: K. Sasaki, G. A. Margonis, N. Andreatos, A. Wilson, M. Weiss, C. Wolfgang et al.
Notes: Antiangiogenesis antibody of benefit
Impact of hepatobiliary service centralization on treatment and outcomes in patients with colorectal cancer and liver metastases. BJS 2017; 104: 918-925.
Authors: A. E. Vallance, J. vanderMeulen, A. Kuryba, I. D. Botterill, J. Hill, D. G. Jayne et al.
Notes: Better survival
Liver transection using indocyanine green fluorescence imaging and hepatic vein clamping. BJS 2017; 104: 898-906.
Authors: Y. Kawaguchi, Y. Nomura, M. Nagai, D. Koike, Y. Sakuraoka, T. Ishida et al.
Notes: To see or not to see
Local tumour progression after percutaneous ablation of colorectal liver metastases according to RAS mutation status. BJS 2017; 104: 760-768.
Authors: B. C. Odisio, S. Yamashita, S. Y. Huang, S. Harmoush, S. E. Kopetz, K. Ahrar et al.
Notes: Mutant RAS poor prognostic factor